JP2013527437A5 - - Google Patents

Download PDF

Info

Publication number
JP2013527437A5
JP2013527437A5 JP2013504499A JP2013504499A JP2013527437A5 JP 2013527437 A5 JP2013527437 A5 JP 2013527437A5 JP 2013504499 A JP2013504499 A JP 2013504499A JP 2013504499 A JP2013504499 A JP 2013504499A JP 2013527437 A5 JP2013527437 A5 JP 2013527437A5
Authority
JP
Japan
Prior art keywords
concentration
subject
ccl8
rheumatoid arthritis
test sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013504499A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013527437A (ja
JP5786020B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2011/059226 external-priority patent/WO2011129382A1/en
Publication of JP2013527437A publication Critical patent/JP2013527437A/ja
Publication of JP2013527437A5 publication Critical patent/JP2013527437A5/ja
Application granted granted Critical
Publication of JP5786020B2 publication Critical patent/JP5786020B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013504499A 2010-04-16 2011-04-07 関節リウマチを診断する方法および試薬 Expired - Fee Related JP5786020B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32502710P 2010-04-16 2010-04-16
US61/325,027 2010-04-16
PCT/JP2011/059226 WO2011129382A1 (en) 2010-04-16 2011-04-07 Methods and reagents for diagnosing rheumatoid arthritis

Publications (3)

Publication Number Publication Date
JP2013527437A JP2013527437A (ja) 2013-06-27
JP2013527437A5 true JP2013527437A5 (enExample) 2014-08-28
JP5786020B2 JP5786020B2 (ja) 2015-09-30

Family

ID=44788487

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013504499A Expired - Fee Related JP5786020B2 (ja) 2010-04-16 2011-04-07 関節リウマチを診断する方法および試薬

Country Status (3)

Country Link
US (1) US9528998B2 (enExample)
JP (1) JP5786020B2 (enExample)
WO (1) WO2011129382A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011129382A1 (en) 2010-04-16 2011-10-20 Abbott Japan Co. Ltd. Methods and reagents for diagnosing rheumatoid arthritis
US10723794B2 (en) * 2015-03-18 2020-07-28 University Of South Carolina Anti-CcL8 antibodies and uses thereof
KR101801092B1 (ko) 2016-01-28 2017-11-28 순천향대학교 산학협력단 특발성 페섬유증 진단용 마커 조성물 및 특발성 폐섬유증 진단을 위한 정보제공방법
WO2018021624A1 (ko) * 2016-07-29 2018-02-01 가톨릭대학교 산학협력단 류마티스 관절염 진단용 바이오마커
EP3824906A1 (en) 2016-12-21 2021-05-26 Amgen Inc. Anti-tnf alpha antibody formulations
CN110740733A (zh) * 2017-06-16 2020-01-31 豪夫迈·罗氏有限公司 Irak4介导的疾患和病症的诊断和治疗方法
EP3688739A1 (en) 2017-09-29 2020-08-05 3M Innovative Properties Company Probe management messages for vehicle-sourced infrastructure quality metrics
FR3072779A1 (fr) * 2017-10-19 2019-04-26 Sinnovial Procede d'estimation de l'efficacite d'un modulateur de la costimulation des lymphocytes t contre la polyarthrite rhumatoide apres reponse inadequate a une biotherapie
CN109142555A (zh) * 2018-05-21 2019-01-04 深圳天祥质量技术服务有限公司 塑料或皮革制品中mccp的测试方法
JP7789336B2 (ja) * 2020-06-04 2025-12-22 学校法人帝京大学 関節リウマチの検出方法
CN113049814A (zh) * 2021-03-26 2021-06-29 南昌大学第二附属医院 血清中类风湿关节炎标志物检测试剂的用途及诊断试剂盒

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
EP0273115B1 (en) 1986-10-22 1994-09-07 Abbott Laboratories Chemiluminescent acridinium and phenanthridinium salts
US5006309A (en) 1988-04-22 1991-04-09 Abbott Laboratories Immunoassay device with liquid transfer between wells by washing
US5089424A (en) 1988-06-14 1992-02-18 Abbott Laboratories Method and apparatus for heterogeneous chemiluminescence assay
US5241070A (en) 1988-09-26 1993-08-31 Ciba Corning Diagnostics Corp. Nucleophilic polysubstituted aryl acridinium esters and uses thereof
US5063081A (en) 1988-11-14 1991-11-05 I-Stat Corporation Method of manufacturing a plurality of uniform microfabricated sensing devices having an immobilized ligand receptor
US5939272A (en) 1989-01-10 1999-08-17 Biosite Diagnostics Incorporated Non-competitive threshold ligand-receptor assays
US5922615A (en) 1990-03-12 1999-07-13 Biosite Diagnostics Incorporated Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network
CA2048302A1 (en) 1990-08-15 1992-02-16 Victoria P. Meucci Solubilization reagent for biological test samples
US5135875A (en) 1990-08-15 1992-08-04 Abbott Laboratories Protein precipitation reagent
WO1992005282A1 (en) 1990-09-14 1992-04-02 Biosite Diagnostics, Inc. Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays
JPH085920B2 (ja) * 1991-01-21 1996-01-24 富士薬品工業株式会社 抗ヒトストロムライシンモノクローナル抗体及び酵素免疫測定法
WO1992018868A1 (en) 1991-04-10 1992-10-29 Biosite Diagnostics Incorporated Crosstalk inhibitors and their uses
DE69231382T2 (de) 1991-04-12 2001-01-25 Biosite Diagnostics Inc., San Diego Neue konjugate und testverfahren für die gleichzeitige bestimmung von multiplen liganden
CA2069530A1 (en) 1991-06-03 1992-12-04 Cass J. Grandone Reagent pack for immunoassays
US5352803A (en) 1992-03-30 1994-10-04 Abbott Laboratories 5(6)-methyl substituted fluorescein derivatives
DE69328622T2 (de) 1992-03-30 2001-02-08 Abbott Laboratories, Abbott Park Reagenzien und verfahren zum nachweis und zur quantifizierung von thyroxin in flüssigen proben
US6143576A (en) 1992-05-21 2000-11-07 Biosite Diagnostics, Inc. Non-porous diagnostic devices for the controlled movement of reagents
US6019944A (en) 1992-05-21 2000-02-01 Biosite Diagnostics, Inc. Diagnostic devices and apparatus for the controlled movement of reagents without membranes
US5824799A (en) 1993-09-24 1998-10-20 Biosite Diagnostics Incorporated Hybrid phthalocyanine derivatives and their uses
US6113855A (en) 1996-11-15 2000-09-05 Biosite Diagnostics, Inc. Devices comprising multiple capillarity inducing surfaces
US5947124A (en) 1997-03-11 1999-09-07 Biosite Diagnostics Incorporated Diagnostic for determining the time of a heart attack
US6303321B1 (en) 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
US6925389B2 (en) 2000-07-18 2005-08-02 Correlogic Systems, Inc., Process for discriminating between biological states based on hidden patterns from biological data
US6890763B2 (en) 2001-04-30 2005-05-10 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1350 daltons
AR037456A1 (es) * 2001-11-30 2004-11-10 Biogen Inc Anticuerpos contra proteinas quimiotacticas monocitarias
US20030224386A1 (en) * 2001-12-19 2003-12-04 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of rheumatoid arthritis
US7419821B2 (en) 2002-03-05 2008-09-02 I-Stat Corporation Apparatus and methods for analyte measurement and immunoassay
US6989100B2 (en) 2002-05-09 2006-01-24 Ppd Biomarker Discovery Sciences, Llc Methods for time-alignment of liquid chromatography-mass spectrometry data
US20040009503A1 (en) * 2002-07-03 2004-01-15 Molecular Staging, Inc. Immune modulatory activity of human ribonucleases
US20040018577A1 (en) 2002-07-29 2004-01-29 Emerson Campbell John Lewis Multiple hybrid immunoassay
US7964194B2 (en) * 2002-11-15 2011-06-21 Morehouse School Of Medicine Anti-chemokine and associated receptor antibodies and uses for inhibition of inflammation
US20040248158A1 (en) * 2003-01-28 2004-12-09 Loughran Thomas P Differentially expressed genes in large granular lymphocyte leukemia
DE602004029058D1 (de) 2003-07-09 2010-10-21 Shinonogi & Co Ltd Inducer von atopischer dermatitis
US7682833B2 (en) 2003-09-10 2010-03-23 Abbott Point Of Care Inc. Immunoassay device with improved sample closure
US7723099B2 (en) 2003-09-10 2010-05-25 Abbott Point Of Care Inc. Immunoassay device with immuno-reference electrode
ES2541683T3 (es) * 2004-02-27 2015-07-23 F. Hoffmann-La Roche Ag Método para evaluar la artritis reumatoide mediante la medición del factor reumatoide y la interleuquina-6
US20070099239A1 (en) 2005-06-24 2007-05-03 Raymond Tabibiazar Methods and compositions for diagnosis and monitoring of atherosclerotic cardiovascular disease
WO2007123976A2 (en) * 2006-04-18 2007-11-01 The Board Of Trustees Of The Leland Stanford Junior University Antibody profiling for determination of patient responsiveness
US7883855B2 (en) 2006-07-21 2011-02-08 Abbott Laboratories Immunosuppressant drug extraction reagent for immunoassays
CA2663730A1 (en) * 2006-09-29 2008-04-03 F. Hoffmann-La Roche Ag Assessing the risk of disease progression for a patient with rheumatoid arthritis
US7906293B2 (en) 2007-04-09 2011-03-15 Abbott Laboratories Acridinium phenyl esters useful in the analysis of biological
ES2473621T3 (es) * 2007-04-18 2014-07-07 Probiodrug Ag Derivados de nitrovinil-diamina como inhibidores de glutaminil ciclasa
CA2692332C (en) 2007-06-22 2019-09-24 Sapporo Medical University Method for detection or treatment of graft versus host disease
WO2010078443A1 (en) 2008-12-31 2010-07-08 Abbott Point Of Care Inc. Method and device for immunoassay using nucleotide conjugates
WO2011129382A1 (en) 2010-04-16 2011-10-20 Abbott Japan Co. Ltd. Methods and reagents for diagnosing rheumatoid arthritis

Similar Documents

Publication Publication Date Title
JP2013527437A5 (enExample)
JP2011503547A5 (enExample)
JP2017538671A5 (enExample)
JP2014506244A5 (enExample)
JP2014533372A5 (enExample)
BR112016004320A2 (pt) biossensor, sistema, kit, métodos de determinação ou de identificação e de quantificação de uma concentração de amônia ou íon amônio, de diagnóstico de uma doença metabólica em um sujeito, de determinação da resposta do paciente a uma terapia, de fabricação de um biossensor, de um sistema ou de qualquer tira de teste e de detecção da presença, ausência, ou quantidade de aminoácidos em uma amostra, e, tira de teste
WO2014074835A3 (en) Antibody compositions and immunoassay methods to detect isoforms of anti-mullerian hormone
Krolewski et al. Progressive renal decline as the major feature of diabetic nephropathy in type 1 diabetes
JP2015533213A5 (enExample)
Yu et al. IFP35 as a promising biomarker and therapeutic target for the syndromes induced by SARS-CoV-2 or influenza virus
JP2014517308A5 (enExample)
JP2025022885A (ja) 重症急性呼吸器症候群(sars)における疾患進行を予後診断するためのプロアドレノメデュリン
JP2013543581A5 (enExample)
McGrath et al. Effect-based proteomic detection of growth promoter abuse
WO2011149272A2 (ko) 단백질분해에 의하여 활성화되는 효소의 활성형의 정성적 및 정량적 분석방법
Lavoie-Lamoureux et al. Optimization of a procedure to accurately detect equine TNFα in serum samples
CN104820042B (zh) 一种采用高效液相色谱法测定样品中卡西酮和4‑甲基甲卡西酮含量的方法
WO2012165926A3 (ko) 항-atic 자가면역항체를 포함하는 간암 진단 마커 및 이의 항원을 포함하는 간암 진단용 조성물
JP2012515893A5 (enExample)
JP2012521549A5 (enExample)
WO2014176167A3 (en) Drug concentration from an oral fluid
JP2009517381A5 (enExample)
JP2021522478A (ja) 選択された患者の心血管疾患を治療するための組成物および方法
PH12013500560A1 (en) Stratification of cancer patients for susceptibility to therapy with ptk2 inhibitors
RU2011105992A (ru) Сорбцинно-флуоресцентный способ определения доксициклина в лекарственных препаратах